These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6606106)

  • 21. [Epidemiologic study on the prevalence of Enterobacter, Serratia and Pseudomonas strains, producers of cefoxitin-inducible beta-lactamases].
    Marone P; Concia E; Perversi L; Cruciani M
    Boll Ist Sieroter Milan; 1986; 65(5):368-73. PubMed ID: 3103651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin].
    Jarlier V; Philippon A; Nicolas MH; Bismuth R; Paul G; Fusciardi J
    Pathol Biol (Paris); 1984 May; 32(5):399-403. PubMed ID: 6739148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
    Moritz VA; Carson PB
    J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae.
    Peter K; Korfmann G; Wiedemann B
    Rev Infect Dis; 1988; 10(4):800-5. PubMed ID: 3263688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of cephamandole against some gram-negative bacilli and staphylococci.
    Dzierzanowska D; Jakubicz P; Niedźwiecka M; Borowski J
    Arch Immunol Ther Exp (Warsz); 1980; 28(3):389-91. PubMed ID: 6969585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of beta-lactamase production by glycine in Enterobacter cloacae ATCC.13047.
    Gatus BJ; Bell SM; Jimenez AS
    Pathology; 1986 Jan; 18(1):145-7. PubMed ID: 3487765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Action of imipenem on Enterobacter cloacae].
    Donnio PY; Lebert P; Travert MF; Avril JL
    Pathol Biol (Paris); 1988 May; 36(5):456-9. PubMed ID: 3043343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of beta-lactamases: in vitro phenomena and clinical relevance.
    Wiedemann B; Peter K
    J Int Med Res; 1990; 18 Suppl 4():58D-66D. PubMed ID: 2282970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae.
    Yang YJ; Livermore DM; Williams RJ
    J Med Microbiol; 1988 Mar; 25(3):227-33. PubMed ID: 3258037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of cefamandole by cefoxitin in routine disk susceptibility tests.
    Sanders CC; Sanders WE
    Am J Clin Pathol; 1980 Apr; 73(4):562-3. PubMed ID: 7369181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefamandole resistance transfer in bacterial strains from two newborn units.
    Krcméry V; Antal M; Havlík J; Knothe H
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(4):409-15. PubMed ID: 3910723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.
    Olson B; Weinstein RA; Nathan C; Kabins SA
    J Antimicrob Chemother; 1983 Apr; 11(4):299-310. PubMed ID: 6602122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro effectiveness of oral cephalosporins, ampicillin and beta-lactamase resistant cephalosporins on enterobacteriaceae].
    Baier R; Puppel H
    Ther Ggw; 1979 Mar; 118(3):317-30. PubMed ID: 311958
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of cefoxitin and clindamycin on selection of derepressed mutants in Enterobacter cloacae.
    Saverino D; Milintenda-Floriani F; Medeiros AA
    New Microbiol; 2004 Jul; 27(3):249-53. PubMed ID: 15460527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cefoxitin, a new beta-lactamase stable antibiotic].
    Simon C; Meyer E; Malerczyk
    Arzneimittelforschung; 1978; 28(9):1541-5. PubMed ID: 314296
    [No Abstract]   [Full Text] [Related]  

  • 40. Third-generation cephalosporins resistance in clinical isolates of Enterobacteriaceae.
    Perduca M; Pagani L; Cereda PM; Debiaggi M
    Microbiologica; 1986 Apr; 9(2):199-207. PubMed ID: 3487023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.